This would definitely fall under the category of causing them a pain in the 'ass', or at least require an independent evaluation: http://www.austlii.edu.au/au//legis//cth//consol_act//ca2001172/s661e.html
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025